32 employees
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
2021
$75M
from 2 investors over 2 rounds
Terremoto Biosciences raised $75M on May 25, 2022
Investors: Third Rock Ventures and OrbiMed Advisors